At the news
? NEUTRALIMPACT 2/10 144 filed Aug 3, 2026 at 17:07 ET
Director Patrick Burnett filed a Form 144 notice of intent to sell 955 shares of Arcutis Biotherapeutics common stock, valued at approximately $24,942. This is a small, routine sale by a director, representing a tiny fraction of the company's $3.4B market cap. The filing is neutral as it signals a planned sale but lacks material size or urgency, and no cross-filing context is present to escalate its significance.
- Director Patrick Burnett filed a Form 144 to sell 955 shares of ARQT common stock.
- Estimated sale value is approximately $24,942 based on the filing date.
- The shares were acquired via restricted stock vesting on August 1, 2026.
- Burnett has sold 906 shares in two prior transactions in May 2026, totaling ~$20,823.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access